New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.


Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
05 2022
Historique:
received: 22 09 2021
accepted: 22 10 2021
pubmed: 17 11 2021
medline: 6 5 2022
entrez: 16 11 2021
Statut: ppublish

Résumé

Various new vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been rapidly developed. The new onset and recurrence of nephrotic syndrome triggered by some vaccines have been documented and several adult cases of minimal change nephrotic syndrome newly developing after SARS-CoV-2 vaccination have been reported. However, no reports of pediatric cases have been published. Indications for SARS-CoV-2 vaccines have been expanded to those as young as 12 years old and vaccination of children has just started in Japan. We encountered a 15-year-old boy without underlying disease who newly developed nephrotic syndrome after SARS-CoV-2 vaccination with BNT162b2 (Pfizer-BioNTech). He developed eyelid edema 4 days after vaccination and peripheral edema of the lower extremities a further 4 days later. Twenty-one days after vaccination, 60 mg of oral daily prednisolone was started. He achieved complete remission in 12 days without complications such as hypertension or acute kidney injury. We clinicians should be aware of the possibility of nephrotic syndrome developing after SARS-CoV-2 vaccination, not only in adults, but also in children.

Identifiants

pubmed: 34782983
doi: 10.1007/s13730-021-00656-0
pii: 10.1007/s13730-021-00656-0
pmc: PMC8592073
doi:

Substances chimiques

COVID-19 Vaccines 0
BNT162 Vaccine N38TVC63NU

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

242-246

Informations de copyright

© 2021. Japanese Society of Nephrology.

Références

Clin Nephrol. 2002 Jul;58(1):68-72
pubmed: 12141410
Pediatr Nephrol. 2018 Apr;33(4):573-584
pubmed: 28451893
Am J Kidney Dis. 2021 Jul;78(1):142-145
pubmed: 33839200
Kidney Int. 2021 Aug;100(2):463-464
pubmed: 34048824
Saudi J Kidney Dis Transpl. 2019 Sep-Oct;30(5):1002-1009
pubmed: 31696837
Nephrol Dial Transplant. 2021 Feb 20;36(3):475-481
pubmed: 31550360
Kidney Int Rep. 2021 Sep;6(9):2523-2524
pubmed: 34337193
N Engl J Med. 2021 Jun 3;384(22):2092-2101
pubmed: 33835769
Nefrologia. 2012 May 14;32(3):414-5
pubmed: 22592437
Vaccine. 2021 Jun 29;39(29):3790-3793
pubmed: 34092429
Kidney Int. 2021 Aug;100(2):459-461
pubmed: 34119510
Kidney Int. 2021 Aug;100(2):461-463
pubmed: 34000278
N Engl J Med. 2021 Jul 15;385(3):239-250
pubmed: 34043894
Clin Neurol Neurosurg. 2004 Mar;106(2):136-8
pubmed: 15003306
Indian J Pathol Microbiol. 2012 Apr-Jun;55(2):239-41
pubmed: 22771654
Clin Nephrol. 2000 Sep;54(3):246-8
pubmed: 11020024
Clin Exp Nephrol. 2012 Aug;16(4):557-63
pubmed: 22358611
J Korean Med Sci. 2021 Aug 02;36(30):e218
pubmed: 34342187
Br Med J. 1972 Dec 16;4(5841):665-6
pubmed: 4264883
Nephrol Dial Transplant. 1998 Jul;13(7):1888-9
pubmed: 9681759
BMC Nephrol. 2009 Aug 05;10:21
pubmed: 19656382
Am J Kidney Dis. 2021 Oct;78(4):607-610
pubmed: 34242687
Am J Kidney Dis. 2021 Aug;78(2):312
pubmed: 33992727
Nature. 2021 Jul;595(7868):572-577
pubmed: 34044428

Auteurs

Eriko Nakazawa (E)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Toru Uchimura (T)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan. toru@yokohama-cu.ac.jp.

Yuji Hirai (Y)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Hayato Togashi (H)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Yoshitaka Oyama (Y)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Aya Inaba (A)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Kentaro Shiga (K)

Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.

Shuichi Ito (S)

Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH